May 12, 2021 | Investors, Press Releases
Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al primo trimestre 2021, positiva pari a euro 104.668 migliaia, e prende atto dello stato di avanzamento dei trials principali Nidlegy™ e Fibromun in linea con le tempistiche previste...May 12, 2021 | 2021, Past Events
A virtual briefing was hosted for sell-side analysts at 9:00am EST / 14:00pm BST / 15:00pm CEST on Thursday 13th May 2021. PRESS RELEASE – 6-05-2021May 12, 2021 | 2021, Press Releases, Scientific
COMUNICATO STAMPA 05-12-2021 PRESS RELEASE – 2021-05-12May 11, 2021 | 2021, Past Events
Philogen will be attending the PEGS Boston Virtual Summit from May 11th to 13th, 2021. Alessandra Villa, Head of Antibody Research will give a lecture with the title “Targeted Immunocytokines” on May 12th. Samuele Cazzamalli, Head of Small Molecule Therapeutics will...May 4, 2021 | 2021, Press Releases, Scientific
Study shows impressive tumor uptake of OncoFAP with unprecedented selectivity against healthy organs. OncoFAP-based molecules are currently being developed for the imaging and therapy of cancer. Philogen announces participation to the 10th World Congress of Melanoma...
Recent Comments